Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 May 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 20 results:
Author Title [ Type(Desc)] Year
Filters: Author is Spoendlin, J.  [Clear All Filters]
Journal Article
J. Spoendlin, Meier, C., Jick, S. S., and Meier, C. R., “Achilles or biceps tendon rupture in women and men with type 2 diabetes: A population-based case-control study”, J Diabetes Complications, vol. 30, pp. 903-9, 2016.
M. Bloechliger, Reinau, D., Spoendlin, J., Chang, S. C., Kuhlbusch, K., Heaney, L. G., Jick, S. S., and Meier, C. R., “Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis”, Respir Res, vol. 19, p. 75, 2018.
J. Spoendlin, Voegel, J. J., Jick, S. S., and Meier, C. R., “Antihypertensive drugs and the risk of incident rosacea”, Br J Dermatol, vol. 171, pp. 130-6, 2014.
J. Spoendlin, Bichsel, F., Voegel, J. J., Jick, S. S., and Meier, C. R., “The association between psychiatric diseases, psychotropic drugs and the risk of incident rosacea”, Br J Dermatol, vol. 170, pp. 878-83, 2014.
J. Spoendlin, Meier, C., Jick, S. S., and Meier, C. R., “Bisphosphonate therapy start may transiently increase the risk of tendon rupture in patients with glucocorticoid co-medication: a population-based observational study”, Pharmacoepidemiol Drug Saf, vol. 25, pp. 1116-1123, 2016.
N. Frey, Jossi, J., Bodmer, M., Bircher, A., Jick, S. S., Meier, C. R., and Spoendlin, J., “The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK”, J Invest Dermatol, vol. 137, pp. 1240-1247, 2017.
N. Frey, Hugle, T., Jick, S. S., Meier, C. R., and Spoendlin, J., “Hyperlipidaemia and incident osteoarthritis of the hand: a population-based case-control study”, Osteoarthritis Cartilage, vol. 25, pp. 1040-1045, 2017.
J. Spoendlin, Voegel, J. J., Jick, S. S., and Meier, C. R., “Migraine, triptans, and the risk of developing rosacea: a population-based study within the United Kingdom”, J Am Acad Dermatol, vol. 69, pp. 399-406, 2013.
J. Spoendlin, Meier, C., Jick, S. S., and Meier, C. R., “Oral and inhaled glucocorticoid use and risk of Achilles or biceps tendon rupture: a population-based case-control study”, Ann Med, vol. 47, pp. 492-8, 2015.
J. Spoendlin, Layton, J. B., Mundkur, M., Meier, C., Jick, S. S., and Meier, C. R., “The Risk of Achilles or Biceps Tendon Rupture in New Statin Users: A Propensity Score-Matched Sequential Cohort Study”, Drug Saf, vol. 39, pp. 1229-1237, 2016.
T. Burkard, Rauch, M., Spoendlin, J., Prieto-Alhambra, D., Jick, S. S., and Meier, C. R., “Risk of hand osteoarthritis in new users of hormone replacement therapy: A nested case-control analysis”, Maturitas, vol. 132, pp. 17-23, 2020.
T. Burkard, Hugle, T., Layton, J. B., Glynn, R. J., Bloechliger, M., Frey, N., Jick, S. S., Meier, C. R., and Spoendlin, J., “Risk of Incident Osteoarthritis of the Hand in Statin Initiators: A Sequential Cohort Study”, Arthritis Care Res (Hoboken), vol. 70, pp. 1795-1805, 2018.
A. M. Mueller, Liakoni, E., Schneider, C., Burkard, T., Jick, S. S., Krahenbuhl, S., Meier, C. R., and Spoendlin, J., “The Risk of Muscular Events Among New Users of Hydrophilic and Lipophilic Statins: an Observational Cohort Study”, J Gen Intern Med, 2021.
R. Schneider, Reinau, D., Stoffel, S., Jick, S. S., Meier, C. R., and Spoendlin, J., “Risk of skin cancer in new users of thiazides and thiazide-like diuretics: a cohort study using an active comparator group”, Br J Dermatol, 2021.
N. Frey, Bodmer, M., Bircher, A., Ruegg, S., Jick, S. S., Meier, C. R., and Spoendlin, J., “The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs”, Epilepsia, vol. 58, pp. 2178-2185, 2017.
J. Spoendlin, Karatas, G., Furlano, R. I., Jick, S. S., and Meier, C. R., “Rosacea in Patients with Ulcerative Colitis and Crohn's Disease: A Population-based Case-control Study”, Inflamm Bowel Dis, vol. 22, pp. 680-7, 2016.
N. Frey, Bodmer, M., Bircher, A., Jick, S. S., Meier, C. R., and Spoendlin, J., “Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study”, Drug Saf, vol. 42, pp. 55-66, 2019.
J. Spoendlin, Voegel, J. J., Jick, S. S., and Meier, C. R., “A study on the epidemiology of rosacea in the U.K”, Br J Dermatol, vol. 167, pp. 598-605, 2012.
N. Frey, Hugle, T., Jick, S. S., Meier, C. R., and Spoendlin, J., “Type II diabetes mellitus and incident osteoarthritis of the hand: a population-based case-control analysis”, Osteoarthritis Cartilage, vol. 24, pp. 1535-40, 2016.
N. Frey, Bircher, A., Bodmer, M., Jick, S. S., Meier, C. R., and Spoendlin, J., “Validation of Stevens-Johnson syndrome or toxic epidermal necrolysis diagnoses in the Clinical Practice Research Datalink”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 429-436, 2017.
[Page last reviewed 4 May 2021]